Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRON TAVI: Intravenous Iron Therapy in Patients Undergoing TAVI
NCT07370688Phase 4Recruiting
- Sponsor
- Erasmus MC
- Start
- Aug 2024
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Erasmus MC. Started Aug 2024; status: recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07370688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07370688.